Product News

Approval for AKEEGA® is based on results from the Phase 3 MAGNITUDE study, a prospectively designed precision medicine study that includes the largest cohort to

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets. Full prescribing information

Biopharmaceutical company AbbVie launches new schools’ prize to help spark an interest in STEM New initiative will be rolled out

Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced today that Erleada®▼(apalutamide) has been granted reimbursement in Ireland for the

Upadacitinib is now approved by the European Commission for the treatment of adult patients with moderately to severely active ulcerative

Windzor Pharma Ireland Ltd is please to announce the launch of SOLFEROL Softgel Capsules,  a range of Vitamin D3 medicines

Roxadustat is the first in a new class of orally administered hypoxia inducible factor prolyl hydroxylase (HIF PH) inhibitors licensed

CIBINQO ® is a once-daily oral treatment with proven efficacy demonstrated in a large-scale clinical trial program Pfizer Healthcare Ireland

Approval is based on data from the Phase 3 CASSIOPEIA trial, which demonstrated that the addition of daratumumab resulted in